Similar articles for PMID: 24309088

Year	Number of Results
1991	1
1992	1
1996	1
2000	2
2002	2
2003	3
2004	3
2005	1
2006	7
2008	4
2009	6
2010	4
2011	6
2012	11
2013	10
2014	5
2015	11
2016	8
2017	19
2018	17
2019	21
2020	29
2021	26
2022	11
2023	6
2024	0

1

Cannabidiol as a potential treatment for psychosis.

Schubart CD, Sommer IE, Fusar-Poli P, de Witte L, Kahn RS, Boks MP. Schubart CD, et al. Eur Neuropsychopharmacol. 2014 Jan;24(1):51-64. doi: 10.1016/j.euroneuro.2013.11.002. Epub 2013 Nov 15. Eur Neuropsychopharmacol. 2014. PMID: 24309088 Review.

2

A systematic review of the antipsychotic properties of cannabidiol in humans.

Iseger TA, Bossong MG. Iseger TA, et al. Schizophr Res. 2015 Mar;162(1-3):153-61. doi: 10.1016/j.schres.2015.01.033. Epub 2015 Feb 7. Schizophr Res. 2015. PMID: 25667194 Review.

3

Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol.

Gomes FV, Llorente R, Del Bel EA, Viveros MP, López-Gallardo M, Guimarães FS. Gomes FV, et al. Schizophr Res. 2015 May;164(1-3):155-63. doi: 10.1016/j.schres.2015.01.015. Epub 2015 Feb 10. Schizophr Res. 2015. PMID: 25680767

4

Cannabidiol and Sodium Nitroprusside: Two Novel Neuromodulatory Pharmacological Interventions to Treat and Prevent Psychosis.

Crippa JA, Hallak JE, Abílio VC, de Lacerda AL, Zuardi AW. Crippa JA, et al. CNS Neurol Disord Drug Targets. 2015;14(8):970-8. doi: 10.2174/1871527314666150909113930. CNS Neurol Disord Drug Targets. 2015. PMID: 26350340 Review.

5

Could cannabidiol be used as an alternative to antipsychotics?

Fakhoury M. Fakhoury M. J Psychiatr Res. 2016 Sep;80:14-21. doi: 10.1016/j.jpsychires.2016.05.013. Epub 2016 May 28. J Psychiatr Res. 2016. PMID: 27267317 Review.

6

Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug.

Zuardi AW, Crippa JA, Hallak JE, Moreira FA, Guimarães FS. Zuardi AW, et al. Braz J Med Biol Res. 2006 Apr;39(4):421-9. doi: 10.1590/s0100-879x2006000400001. Epub 2006 Apr 3. Braz J Med Biol Res. 2006. PMID: 16612464 Free article. Review.

7

The Potential of Cannabidiol Treatment for Cannabis Users With Recent-Onset Psychosis.

Hahn B. Hahn B. Schizophr Bull. 2018 Jan 13;44(1):46-53. doi: 10.1093/schbul/sbx105. Schizophr Bull. 2018. PMID: 29083450 Free PMC article. Review.

8

Cannabidiol for the treatment of psychosis in Parkinson's disease.

Zuardi AW, Crippa JA, Hallak JE, Pinto JP, Chagas MH, Rodrigues GG, Dursun SM, Tumas V. Zuardi AW, et al. J Psychopharmacol. 2009 Nov;23(8):979-83. doi: 10.1177/0269881108096519. Epub 2008 Sep 18. J Psychopharmacol. 2009. PMID: 18801821

9

The relationship between cannabidiol and psychosis: A review.

Silva TB, Balbino CQ, Weiber AF. Silva TB, et al. Ann Clin Psychiatry. 2015 May;27(2):134-41. Ann Clin Psychiatry. 2015. PMID: 25954940 Review.

10

A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation.

Zuardi AW, Crippa JA, Hallak JE, Bhattacharyya S, Atakan Z, Martin-Santos R, McGuire PK, Guimarães FS. Zuardi AW, et al. Curr Pharm Des. 2012;18(32):5131-40. doi: 10.2174/138161212802884681. Curr Pharm Des. 2012. PMID: 22716160 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

187 results

Results by year